University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Lewis S. Blevins

Lewis S. Blevins, M.D.

Neuro-endocrinologist

Dr. Lewis Blevins is an endocrinologist specializing in the evaluation and management of pituitary and hypothalamus disorders, including acromegaly, prolactinoma, other pituitary tumors, diabetes insipidus, hypopituitarism and growth hormone deficiencies. As medical director of the California Center for Pituitary Disorders at UCSF Medical Center, Blevins directs a team providing comprehensive, state-of-the-art care. He has a special interest in Cushing's syndrome and has edited a book on the subject.

In his research, he is interested in evaluating new diagnostics for hypercortisolism and Cushing's syndrome, and the clinical predictors of surgical and medical successes with pituitary tumors. Blevins earned a medical degree at Quillen College of Medicine at East Tennessee State University and completed a residency in internal medicine at University of Alabama Hospitals. After completing a fellowship in endocrinology at Johns Hopkins Hospital, he served on the faculty at Emory University for four years and at Vanderbilt University for nine years.

Conditions & Treatments

Clinics

California Center for Pituitary Disorders
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (866) 559-5543

Fax: (415) 353-2939

Hours: Monday to Friday
8 a.m. – 5 p.m.

Neuro-Oncology Clinic
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-2966
Fax: (415) 353-2167

Hours: Monday to Friday
8 a.m. – 5 p.m.

More about Lewis S. Blevins

Education

Quillen College of Medicine 1987

Residencies

University of Alabama Hospitals, Internal Medicine 1990

Fellowships

Johns Hopkins Hospital, Endocrinology 1993

Selected Research and Publications

  1. Rolston JD, Blevins LS. Gamma knife radiosurgery for acromegaly. Int J Endocrinol. 2012; 2012:821579.
  2. Potts MB, Jahangiri A, Lamborn KR, Blevins LS, Kunwar S, Aghi MK. Suprasellar Rathke cleft cysts: clinical presentation and treatment outcomes. Neurosurgery. 2011 Nov; 69(5):1058-68; discussion 1068-7.
  3. Sughrue ME, Chang EF, Gabriel RA, Aghi MK, Blevins LS. Excess mortality for patients with residual disease following resection of pituitary adenomas. Pituitary. 2011 Sep; 14(3):276-83.
  4. Potts MB, DeGiacomo AF, Deragopian L, Blevins LS. Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion. Neurosurgery. 2011 Aug; 69(2):268-73.
  5. Jahangiri A, Lamborn KR, Blevins L, Kunwar S, Aghi MK. Factors associated with delay to pituitary adenoma diagnosis in patients with visual loss. J Neurosurg. 2012 Feb; 116(2):283-9.
  6. Jahangiri A, Molinaro AM, Tarapore PE, Blevins L, Auguste KI, Gupta N, Kunwar S, Aghi MK. Rathke cleft cysts in pediatric patients: presentation, surgical management, and postoperative outcomes. Neurosurg Focus. 2011 Jul; 31(1):E3.
  7. Tarapore PE, Sughrue ME, Blevins L, Auguste KI, Gupta N, Kunwar S. Microscopic endonasal transsphenoidal pituitary adenomectomy in the pediatric population. J Neurosurg Pediatr. 2011 May; 7(5):501-9.
  8. Chang EF, Sughrue ME, Zada G, Wilson CB, Blevins LS, Kunwar S. Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas. Pituitary. 2010 Sep; 13(3):223-9.
  9. Tate MC, Jahangiri A, Blevins L, Kunwar S, Aghi MK. Infected Rathke cleft cysts: distinguishing factors and factors predicting recurrence. Neurosurgery. 2010 Sep; 67(3):762-9; discussion 769.
  10. Sughrue ME, Shah JK, Devin JK, Kunwar S, Blevins LS. Utility of the immediate postoperative cortisol concentrations in patients with Cushing's disease. Neurosurgery. 2010 Sep; 67(3):688-95; discussion 695.
  11. Sughrue ME, McDermott M, Blevins LS. Extreme correction of hyponatremia in a patient treated with intravenous conivaptan. J Clin Neurosci. 2010 Oct; 17(10):1331-4.
  12. Aghi M, Blevins LS. Recent advances in the treatment of acromegaly. Curr Opin Endocrinol Diabetes Obes. 2009 Aug; 16(4):304-7.
  13. Blevins LS, Sanai N, Kunwar S, Devin JK. An approach to the management of patients with residual Cushing's disease. J Neurooncol. 2009 Sep; 94(3):313-9.
  14. Terhune KP, Jagasia S, Blevins LS, Phay JE. Diagnostic and therapeutic dilemmas of hypercortisolemia during pregnancy: a case report. Am Surg. 2009 Mar; 75(3):232-4.
  15. Sughrue ME, Chang EF, Tyrell JB, Kunwar S, Wilson CB, Blevins LS. Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection. Pituitary. 2009; 12(3):158-64.
  16. Devin JK, Lakhani VT, Byrd BF, Blevins LS. Prevalence of valvular heart disease in a cohort of patients taking cabergoline for management of hyperprolactinemia. Endocr Pract. 2008 Sep; 14(6):672-7.
  17. Devin JK, Vaughan DE, Blevins LS, Chen Q, Covington J, Verity DK, Young PP. Low-dose growth hormone administration mobilizes endothelial progenitor cells in healthy adults. Growth Horm IGF Res. 2008 Jun; 18(3):253-63.
  18. Dossett LA, Rudzinski ER, Blevins LS, Chambers EP. Malignant pheochromocytoma of the organ of Zuckerkandl requiring aortic and vena caval reconstruction. Endocr Pract. 2007 Sep; 13(5):493-7.
  19. Devin JK, Blevins LS, Verity DK, Chen Q, Bloodworth JR, Covington J, Vaughan DE. Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency. J Clin Endocrinol Metab. 2007 Sep; 92(9):3633-9.
  20. Devin JK, Blevins LS. Visual vignette. Hypopituitarism with central diabetes insipidus attributable to traumatic brain injury. Endocr Pract. 2006 Jan-Feb; 12(1):108.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2012 The Regents of The University of California